Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
As of close of business last night, Allogene Therapeutics Inc’s stock clocked out at $1.38, down -1.43% from its previous closing price of $1.4. In other words, the price has decreased by -$1.43 from its previous closing price. On the day, 2.2 million shares were traded. ALLO stock price reached its highest trading level at $1.42 during the session, while it also had its lowest trading level at $1.36.
Ratios:
To gain a deeper understanding of ALLO’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 8.19 and its Current Ratio is at 8.19. In the meantime, Its Debt-to-Equity ratio is 0.27 whereas as Long-Term Debt/Eq ratio is at 0.24.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 17 ’25 when Beneski Benjamin Machinas sold 786 shares for $1.22 per share. The transaction valued at 959 led to the insider holds 217,721 shares of the business.
Beneski Benjamin Machinas bought 786 shares of ALLO for $959 on Nov 17 ’25. On Oct 21 ’25, another insider, Parker Geoffrey M., who serves as the CHIEF FINANCIAL OFFICER of the company, sold 36,744 shares for $1.26 each. As a result, the insider received 46,169 and left with 1,276,796 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALLO now has a Market Capitalization of 310127584 and an Enterprise Value of 143075600.
Stock Price History:
The Beta on a monthly basis for ALLO is 0.51, which has changed by -0.34285712 over the last 52 weeks, in comparison to a change of 0.17318606 over the same period for the S&P500. Over the past 52 weeks, ALLO has reached a high of $3.78, while it has fallen to a 52-week low of $0.86. The 50-Day Moving Average of the stock is 4.88%, while the 200-Day Moving Average is calculated to be 5.84%.
Shares Statistics:
It appears that ALLO traded 2.67M shares on average per day over the past three months and 2707910 shares per day over the past ten days. A total of 223.16M shares are outstanding, with a floating share count of 160.22M. Insiders hold about 28.68% of the company’s shares, while institutions hold 50.55% stake in the company. Shares short for ALLO as of 1765756800 were 18038394 with a Short Ratio of 6.75, compared to 1763078400 on 18695485. Therefore, it implies a Short% of Shares Outstanding of 18038394 and a Short% of Float of 9.659999599999999.
Earnings Estimates
The firm’s stock currently is rated by 10.0 analysts. The consensus estimate for the next quarter is -$0.22, with high estimates of -$0.18 and low estimates of -$0.27.
Analysts are recommending an EPS of between -$0.74 and -$1.2 for the fiscal current year, implying an average EPS of -$0.94. EPS for the following year is -$0.91, with 10.0 analysts recommending between -$0.43 and -$1.47.
